Annual Drug Patent Expirations for PROAIR+DIGIHALER
Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug.
Drug patent litigation for PROAIR DIGIHALER.
This drug has two hundred and ninety-six patent family members in thirty-one countries.
The generic ingredient in PROAIR DIGIHALER is albuterol sulfate. One supplier is listed for this compound. Additional details are available on the albuterol sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com